Analysis of the following: appearance, proton NMR, infrared, hplc (assay, impurity), residual solvents, moisture (KF), residue on ignition, heavy metals for NSC 706744 (LMP-744, 1 lot).
Ended Awarded Last action
- Contract number
- 75N91020F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $26,166
Award facts
- Opportunity
-
- N02CM7700416 Solicitation number
- Analysis of Anti-Cancer Chemicals & Pharmaceutical Formulations Award Notice · Posted Feb 22, 2017
- Analysis of Bulk Drugs & Pharmaceutical Formulations Award Notice · Posted Dec 9, 2016
- Contract value 100% obligated
- $26,166.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$278 | |
| Original award | $26,444 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency, to SRI International, a non-profit research and development institute. The $26,166.42 contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations, including tests for appearance, NMR, IR, HPLC, residual solvents, moisture, residue on ignition, and heavy metals for a specific chemical compound, NSC 706744. This contract is part of a larger $26.2 million indefinite delivery vehicle (IDV) with the National Cancer Institute focused on analysis of anti-cancer chemicals and pharmaceuticals, which SRI International has been awarded. There is no set-aside designation for this contract.
Quick answers
Who was awarded contract 75N91020F00001?
75N91020F00001 was awarded to Sri International by National Cancer Institute (National Institutes of Health) on January 2, 2020.
How much is contract 75N91020F00001 worth?
The government has obligated $26,166 on 75N91020F00001.
Is contract 75N91020F00001 an order under another contract?
Yes. 75N91020F00001 is a delivery order under HHSN261201700014I, an indefinite delivery contract, on NIH Analysis of Anti-Cancer Chemicals 2017-2022.
Was contract 75N91020F00001 competed?
The extent of competition for 75N91020F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award